Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hypnosis for your stomach? tiny study tests Gut-Directed therapy online

NCT ID NCT06890663

Symptom relief Sponsor: University of Central Florida Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether gut-directed hypnotherapy (GDH) delivered via telehealth could help manage gastrointestinal symptoms in adults with disorders of gut-brain interaction. Eleven participants completed sessions of general relaxation hypnosis and GDH, plus a 3-month follow-up. The goal was to see if this approach eases symptoms like pain or bloating without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
gut-directed hypnotherapy (GDH) delivered via telehealth
What this could lead to
If it works, this could offer a non-drug option to ease gut symptoms like bloating or pain by using relaxation and hypnosis.
What could go wrong
This is a very small, completed study with only 11 participants, so results may not apply to everyone. Hypnotherapy may not work for all types of gut issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

11 people

The number who actually took part.

Started

Mar 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years or older * Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction * English speaking * Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys Exclusion Criteria: * Under 18 years * Pregnant women * Prisoners * Children * Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders) * A hypnotic susceptibility score in the low range (SHSS; total = 0-3)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastrointestinal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

digestive system disorder gastroesophageal reflux disease irritable bowel syndrome nervous system disorder Neurologic Manifestations

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastrointestinal disease Gastrointestinal disorders Nervous system

Contacts and locations

Locations

  • University of Central Florida

    Orlando, Florida, 32816, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.